NCT07162012
- Conditions
- DLBCL, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Shanghai General Hospital Shanghai, China
Clinical trial condition
Lymphoma, T-Cell
Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.
701 public trials
104 recruiting studies
Lymphoma, T-Cell trial results
NCT05770037
- Conditions
- Adenocarcinoma, Anaplastic Large Cell Lymphoma, Cancer, +37 more
- Locations
-
- Belfast City Hospital Belfast, United Kingdom
- University Hospital Birmingham Birmingham, United Kingdom
- Birmingham Children's Hospital Birmingham, United Kingdom
- Bristol Royal Hospital for Children Bristol, United Kingdom
NCT01137643
- Conditions
- Amyloidosis, Anemia, Anemia, Aplastic, +98 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
NCT02848274
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- City of Hope Duarte, California, United States
- Stanford University, School of Medicine Palo Alto, California, United States
- University of Iowa Iowa City, Iowa, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
NCT06947967
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Recruiting
Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma
NCT06160843
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- National Cancer Centre, Singapore Singapore
NCT07021495
- Conditions
- Abscess, Angioedema, Atopic Dermatitis (AD), +56 more
- Locations
-
- Radboud University Medical Center Nijmegen, Gelderland, Netherlands
- Maastricht University Medical Center+ Maastricht, Limburg, Netherlands
- Amsterdam University Medical Center Amsterdam, North Holland, Netherlands
- University Medical Center Groningen Groningen, Provincie Groningen, Netherlands
Recruiting
Bendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients
NCT07072221
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT07000617
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
- Locations
-
- National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China
- Peking University Cancer Hospital Beijing, China
- Peking University International Hospital Beijing, China
NCT06244368
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC Tianjin, Tianjin Municipality, China